Transparency Market Research (TMR) has published a research study on the global market for molecular cytogenetics, estimating it to report an exceptional CAGR of 23.40% during the period from 2013 to 2019 and reach a value of US$1.9 bn by the end of the forecast period.The market report, titled “Molecular Cytogenetics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, further states that the worldwide global molecular cytogenetics market had reached US$0.4 bn in 2012.

Get Report Sample and Customization:
http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1185

According to the analysis, the increasing incidence of cancer, as well as the introduction of modern and highly developed technologies for molecular cytogenesis, has boosted the global molecular cytogenetics market extensively. However, the lack of accuracy and transparency in medical reimbursement policies is likely to hamper the growth of this market over the next few years.The report has assessed the worldwide market for molecular cytogenetics on the basis of technology and application. Based on technology, this market has been classified into the aCGH segment and the FISH segment.

Currently, the aCGH segment is posting a substantial rise in market share, owing to the increasing demand for this technique as it provides accurate analysis and rapid high-resolution results. Its ability to perform a number of experiments in a single group, thus saving time and money, is another reason for its immense popularity across the world. Analysts at TMR project this segment to expand at a CAGR of more than 20% and dominate the global market over the forecast period. Genetic disorders, personalized medicines, and cancer treatment are considered as the key application areas for molecular cytogenetics.

The study also analyzes the global molecular cytogenetics market on the basis of its regional distribution. As per the report, North America currently holds the leading position among all the regional markets for molecular cytogenetics. The increasing awareness among people regarding molecular biology and cytogenetics for the treatment of genetic disorders, together with a growing pool of research laboratories, is fueling this market in North America to a great extent

Europe is also showing impressive growth in its market share, owing to the development of customized medicines for the treatment of cancer.Asia Pacific is projected to register the fastest growth during the forecast period. The increasing frequency of genetic diseases is propelling the molecular cytogenetics market in this region significantly, presenting an opportunity-rich market for participants, says the market study.

Abbott Laboratories, Agilent Technologies Inc., Affymetrix Inc., Applied Spectral Imaging Inc., Bio-Rad Laboratories, BI Biological Industries, CytoTest Inc., F. Hoffmann-La Roche Ltd., Cytognomix Inc., Illumina Inc., Life Technologies Corp., Leica Biosystems, Oxford Gene Technology, Life Technologies Corp., SciGene Corp., and PerkinElmer Inc. are the key players operating in the global market for molecular cytogenetics, states the research report.

Full Research Report on Global Molecular Cytogenetics Market: 
http://www.transparencymarketresearch.com/molecular-diagnostics-market.html

The global molecular cytogenetics market is segmented into:

By Technology

• FISH
• aCGH

By Application

• Genetic Disorders
• Cancer
• Personalized Medicine
• Others

By Region

• North America
• Europe
• Asia Pacific
• Rest of the World